Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone. Happy to move to our next session on the second day of the JPMorgan conference. I'm Robbie Marcus, the medtech analyst here. And we have the Boston Scientific management team. CEO, Mike Mahoney's going to kick it off with a formal presentation, and then we're going to move into Q&A, along with Dr. Ian Meredith and Dan Brennan, the CFO.
So just a few quick housekeeping items. Feel free to go to the JPMorgan health care website and get the slides for the presentation. Feel free to go ahead and put a question there. And then you could also e-mail me or get me on Bloomberg chat. And I can do my best to ask your questions.
So with that, go ahead. And I will join you for Q&A.
Thank you very much, Robbie. We appreciate the opportunity, and thanks again for all of your interest.
2020 certainly offers challenges, but I'm very proud of how the BSC team
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |